Antibiotics Events Announce Your Event Here

No upcoming events


Liverpool, UK

The 16th Pseudomonas International Conference takes place between the 5th-9th of September. This event is biennial and brings together researchers from all over the world who are working on the genus Pseudomonas, including not only the important human pathogen Pseudomonas aeruginosa, but also a range of other important species with relevance to plant pathogenicity, bioremediation and environmental microbiology. It is also a group of organisms used widely for the study of host-pathogen interactions; cell-cell communication systems; evolutionary biology; gene regulation and metabolic networks; secretion systems; antibiotics (and resistance); bioremediation; biofilms; bacterial genomics; and other topics of broader relevance to microbiology and molecular biology generally.

21–25 April 2018 Experimental Biology 2018

San Diego, CA, USA

Experimental Biology is the annual meeting of five societies comprised of more than 14,000 scientists and 25 guest societies.

Primary focus areas include anatomy, biochemistry and molecular biology, investigative pathology, nutrition, pharmacology, and physiology. EB 2018 is open to everyone with interest in the latest research impacting life sciences. Attendees represent scientists from academic institutions, government agencies, non-profit organizations and industry.

This multidisciplinary, scientific meeting features plenary and award lectures, workshops, oral and posters presentations, on-site career services and exhibits spotlighting equipment, supplies and publications required for research labs and experimental study.

Our booth number is #1034 and we are looking forward to welcome you at Experimental Biology 2018 in San Diego!

Find out more at

25–26 April 2018 The 3rd International Conference on Polymyxins

Madrid, Spain

The International Conference on Polymyxins is a gathering of the world’s leading opinion-leaders to discuss the cutting-edge of polymyxin research and clinical use. The 3rd iteration of this conference will occur from April 25–26, 2018, in Madrid, Spain. Over 30 presentations by world leaders will be provided to: highlight recent accomplishments in the field, deliver updates on toxicity, describe advances in the use of polymyxin-based combinations, summarize regulatory and world health perspectives of polymyxin use, discuss recent discoveries in polymyxin resistance, provide updates regarding susceptibility testing, project the future role of polymyxins, and provide a roadmap for future research.

Please find out more on offical website.

29 July–3 August 2012 Drug Resistance: A Multidisciplinary Exploration of Similarities in Drug Resistance in Rapidly Evolving Diseases

Easton, MA, USA

The occurrence of drug resistance negatively impacts the lives of millions of patients by limiting the longevity of many of our most potent drugs. In most cases, drug resistance is investigated as a disease specific endeavor, with no centralized, cross-disciplinary network in the world, limiting intellectual progress and breakthroughs. Clinicians and researchers are often unaware of the progress, resources and parallels in other diseases. However, it is increasingly clear that close parallels can often be drawn between resistance seen in one disease state and resistance seen within another. Cross-disciplinary collaboration and discussion are permitting a better understanding of resistance and may soon result in real clinical benefits. The new Gordon Research Conference entitled "Drug Resistance" is devoted to recognizing the parallels among quickly evolving diseases. The goal is to bring the challenge of drug resistance to the forefront of drug design strategies.

25–28 September 2012 International Symposium Alternatives to Antibiotics (ATA)

Paris, France

The symposium will focus on the latest scientific breakthroughs and technologies that provide new options and alternative strategies for preventing and treating diseases of animals. Some of these new technologies have direct applications as medical interventions for human health, but the focus of the symposium is animal production, animal health, and food safety. The following five areas will be explored in detail through scientific presentations and expert panel discussions:

  1. Alternatives to antibiotics: lessons from nature
  2. Altering innate defense mechanisms to enhance disease resistance
  3. The gut microbiome and immune development, health and diseases
  4. Alternatives to antibiotics for use as growth promotants
  5. Regulatory pathways to enable the licensure of alternatives to antibiotics

4–5 October 2012 2nd ARIP Conference 2012

Vilnius, Lithuania

The groundbreaking series of the ARIP Conferences will provide an unique meeting place to bring together scientists and experts in all major fields of antimicrobial resistance and infection prevention. The Conferences will feature internationally recognized invited speakers, oral presentations and poster sessions, and will provide an ideal platform for continuing education.

8–10 October 2012 Max Rubner Conference 2012 - Antibiotics in the Food Chain

Karlsruhe, Germany

The Max Rubner-Institut is holding a scientific conference on “Antibiotics in the Food Chain” from 8 to 10 October 2012 in Karlsruhe – from the analysis of antibiotics and their degradation products, the status quo on residues in various groups of foodstuffs, microbiological aspects of antibiotic resistances, and the impact on humans to the strategies for addressing the issue.

29–31 January 2013 Antibiotics Conference - Current Issues for the Poultry & Egg Industry

Atlanta, GA, USA

The Antibiotics Conference aims to explore and discuss global antibiotics use as viewed from the regulatory and scientific perspective of leading industry experts. For the first time at the International Poultry Expo, experts from the United States, Europe, and Latin America will discuss the current use of antibiotics throughout the world, explore the differences in regional perspectives involving antibiotics, investigate how antibiotic use is monitored, and review the current science behind alternatives to antibiotics. An FDA official will discuss the agency’s plans for future oversight of antibiotics use in the United States.

21–23 February 2013 Antimicrobials 2013

Sydney, Australia

The programme’s symposia cover many different aspects on antimicrobials and sessions include “”Resistance to Enterobacteriacae”: “Enterococci”, “Current Treatment Challenges”, “Antimicrobial Stewardship” and, “How to Roll Out EUCAST (Bacteriology)”.   In addition we have two pharmacy workshops on Saturday afternoon titled “Antimicrobial Stewardship - the How to?” and “Bugs and Drugs”. Four proffered papers and two poster sessions are also planned for the meeting. Once again ASA is offering travel awards to financial members of the Society who are submitting abstracts for the meeting. These awards include return economy airfare, registration and accommodation. In addition the ASA/bioMérieux travel award will be awarded during the meeting to an abstract dealing with the identification of antimicrobial resistance in a routine clinical setting.
To promote discussion and interaction between delegates and the invited speakers the meeting’s registration includes lunches, morning and afternoon teas and admission to the Welcome and Industry Receptions. I am confident that you will find the meeting’s programme both scientifically stimulating and informative and we look forward to meeting you in Sydney.

24 February–1 March 2013 Antimicrobial Peptides: Discovery, Function and Application

Ventura, CA, USA

Antimicrobial peptides (AMPs) are host-defense molecules produced by all living organisms, including bacteria, fungi, plants, invertebrates, and vertebrates. The peptides exhibit potent cytotoxic activity against all microbes, including bacteria, fungi, viruses, and parasites. There is now evidence in humans and other mammals that these peptides represent a key component of host defense at epithelial surfaces, the barrier between the external environment and the interior milieu, interacting with both symbionts and pathogens. Members of these large families also have activities far beyond being directly antimicrobial, including immunity, wound healing, fertility, and as ligands for numerous receptors leading to the induction of a variety of signaling pathways. Furthermore, significant research has been carried out to develop these naturally occurring peptides as therapeutic agents against microbial infections.

13–15 March 2013 OIE Global Conference on the Responisble and Prudent Use of Antimicrobial Agents for Animals

Paris, France

Antimicrobial agents are essential tools for protecting animal health and welfare. They also contribute to satisfying the increasing world demand for safe food of animal origin, such as milk, meat and eggs. To ensure sustainability of livestock production, the efficacy of antimicrobial agents must be preserved through their responsible and prudent use.

14 March 2013 British Society for Antimicrobial Chemotherapy (BSAC) Spring Meeting 2013

London, UK

Entitled Gram negative, gram positive, fungal and beyond – the increasing complexities of “everyday” infection the meeting will provide state of the art overviews on the epidemiology, diagnosis and treatment of once familiar infections that are becoming increasingly difficult to manage in everyday practice.

27–30 April 2013 23rd European Congress of Clinical Microbiology and Infectious Diseases

Berlin, Germany

Both international and local committees are working hard and with great enthusiasm on a programme focused on
the latest developments in Clinical Microbiology and Infectious Diseases. The congress not only includes keynote lectures, meet-the-expert, poster sessions and integrated symposia, but also offers an educational opportunity
for young colleagues and beginners in the field. You will benefit from state-of-the-art updates in various aspects of Infectious Diseases as well as a unique opportunity to network with ESCMID Study Groups and other scientific groups from all over the world. Make a difference! Meet your friends and colleagues, share ideas, plan ahead and
shape the future.

18–21 May 2013 American Society Of Microbiology 113th General Meeting 2013 (ASM 2013)

Denver, Colorado, USA

asm2013 promises to showcase and deliver the latest advances in science surrounding microbes in the biosphere. The comprehensive meeting format of asm2013 will offer educational plenary sessions focused on topics of broad interest alongside symposia focused on distinct areas of research.

21–23 May 2013 International Scientific Conference on Bacteriocins and Antimicrobial Peptides

Kosice, Slovakia

The scientific programme will focus on current advances in the science and research of bacteriocins and antimicrobial peptides.

At BAMP2013 leading scientists from industry and academia will present and will discuss current advances in the research of bacteriocins and antimicrobial peptides. Key themes will be isolation, characterization, mechanism-of-action, food, clinical and veterinary applications of novel or already characterized bacteriocins produced by lactic or non-lactic acid bacteria.

21–25 July 2013 The 5th Congress of European Microbiologists (FEMS 2013)

Leipzig, Germany

The 5th Congress of European Microbiologists (FEMS) will be held in the interesting city of Leipzig from July 21-25, 2013. FEMS brings together 46 member societies from 36 European countries, including over thirty thousand microbiologists. This important microbiology Congress will provide an interesting forum for thousands of European and other international colleagues to appreciate the current state of the art in microbiology during numerous symposia and workshops led by prominent scientists in their field. The meeting will be a chance to discuss solutions to future challenges and to provide topical coverage of key disciplines. Special attention will also be given to young scientists by providing an important number of grants allowing them to attend the Congress.

Examples of key areas will be:

Biofilms in ecology and medicine
Clinical microbiology and pathogenesis
Eukaryotic microbes
Food microbiology
Microbial stress responses
Molecular microbiology and genomics
Veterinary microbiology

2–3 August 2013 ttp:// 4. Australasian Society For Infectious Diseases Gram-Negative Superbugs Meeting 2013 (ASID 2013)

Queensland, Australia

Antibiotics form the cornerstone of modern medicine but their use is now under threat from the rapid growth in antimicrobial resistance. Together, clinicians, microbiologists, pharmacists, infection control nurses, researchers can halt this trend but it will require co ordinated action, education and innovation. Attend the Gram-Negative "Superbugs" Meeting in the Gold Coast in August to hear about latest developments and be a part of efforts to define the Australian and regional response to this crisis.

28–30 August 2013 Nobel Conference on Biofilm Formation, Its Clinical Impact and Potential Treatment

Stockholm, Sweden

This interdisciplinary Nobel conference ‘Biofilm formation, its clinical impact and potential treatment’ aims to cover recent progress in the research area of biofilm formation. The conference will gather leading researchers from the pre-clinical and clinical side who collectively cover the broad spectrum of biofilm research from the molecular analysis of basic phenomena over the clinical impact to approaches to prevent biofilm formation.

2–4 September 2013 Society For General Microbiology Autumn Meeting 2013 (SGM 2013)

University of Sussex, UK

This exciting conference will appeal to microbiologists from a variety of different backgrounds, especially those interested in infectious disease. Symposia over the three days will cover many different areas of microbiology, including prokaryote and eukaryote research.

Impact of bacteriophage in the environment will cover the increasing awareness and impact of bacteriophage on the ecology of the biosphere, while Microbial modulation of cellular responses will highlight the way different bacterial toxins and effectors subvert, inhibit or activate host-cell pathways to the benefit of pathogens. Pathogen genomics – current clinical applications will show how clinical practice is changing based on the data generated by next generation sequencing technology, and Regulatory phosphate-based molecules will outline progress in understanding the actions of phosphate-based regulatory molecules.

5–8 September 2013 Nordic Society Of Clinical Microbiology And Infectious Diseases 30th Annual Meeting 2013 (NSCID 2013)

Aarhus, Denmark

On behalf of NSCMID, we are pleased to invite you to the 30th annual meeting of NSCMID, which will be held in Aarhus, Denmark on 5-8 September 2013.

The scientific topic is Nordic perspectives on global and emergent infections and we have created an attractive scientific programme covering relevant topics of infectious diseases and microbiology ranging from basic to clinical science.

10–13 September 2013 Interscience Conference On Antimicrobial Agents And Chemotherapy 2013 (ICAAC 2013)

Denver, USA

ICAAC 2013 is designed to meet the needs of health care professionals, particularly physicians, clinical microbiologists, researchers, and pharmacists, specializing in infectious diseases. Current trends will be covered regarding:

  • Antimicrobial Resistance
  • Clinical Trials
  • Community-Acquired Infections
  • Epidemiology Pharmacology
  • HIV/AIDS and other Retroviruses
  • Laboratory Diagnostics
  • Microbial Pathogenesis
  • Mycology
  • Nosocomial Infections
  • Parasitology
  • Susceptibility Studies
  • Transplantion
  • Travel Medicine
  • Vaccines and Immunology
  • Virology

17–19 September 2013 Influenza 2013

Oxford, UK

Influenza2013 will address most aspects of basic and applied research on zoonotic and human influenza viruses. The conference invites proposals for podium sessions and poster displays in the following general areas:-

  • Molecular virology and immunology
  • Antiviral drug development and treatment strategies, including vaccination
  • Host-pathogen interaction - virulence and pathogenecity
  • Epidemiology and evolution
  • Mathematical models
  • National and international surveillance and contingency strategies
  • Advances in viral detection and identification technologies

24–27 September 2013 ICCA-13: 13th International Conference on the Chemistry of Antibiotics and other bioactive compounds

Yamanashi, Japan

The main purpose of this International Conference is discussing important issues which researches of bioactive and biological active substances derived from microorganisms containing antibiotics are facing from a chemical standpoint.
A high level of discussion has been always developed so far, and important proposals leading to future perspectives of not only basic study but also application study of synthetic organic chemistry, pharmaceutical chemistry and microbial chemistry have been made.

The outcome thereof has been highly evaluated each time and made large impacts internationally and this International Conference is now approved as one of renowned international conferences in the world.

30 September–2 November 2013 Infection Prevention 2013

London, UK

Infection Prevention 2013 is hosted by the Infection Prevention Society (IPS) and is the UK's largest infection prevention and control event.  With an exciting programme on offer, this event promises to offer delegates the latest in infection prevention research, education and expertise, with inspiring speakers and informative sessions. The exhibition is the largest of its kind in the UK with over 110 exhibiting companies displaying products relevant to those in the infection prevention sector.

14–16 October 2013 EMBO | EMBL Symposium: New Approaches And Concepts In Microbiology 2013

Heidelberg, Germany

This meeting aims to bridge the gap between traditional microbiology and systems approaches-novel technologies, by exposing microbiologists to new ways of addressing their hypotheses, and allowing systems or technology experts to get a feeling of the burning questions in the field and/or find collaborators for follow-up work or for applying their technology.

This symposium is a must-attend conference for scientists working with bacteria and new technologies, and will turn into a series. The symposium series will remain in the interface of new technologies and new biology in prokaryotic organisms, but the biological focuses and organizers will regularly change.


  • Systems Microbiology
  • Antibiotics & Chemical Genomics
  • Cell Biology & Single-cell approaches
  • Bacterial communities
  • Pathogenesis
  • Regulation, Signaling & Transcriptional Networks

11–13 November 2013 Federation Of Infection Societies Meeting 2013 - Action On Infection (FIS 2013)

Birmingham, UK

The FIS (Federation of Infection Societies) Annual Conference is a collaboration between all organisations who have an interest in infection from across the UK. In 2013, BSAC (British Society for Antimicrobial Chemotherapy) will host the three day event on behalf of all societies at the prestigious ICC in the heart of Birmingham.

The programme features state of the art plenary and parallel sessions, workshops and much more. The agenda covers the full spectrum of infection prevention, research, diagnosis and treatment which will provide a fantastic opportunity for all involved to learn the latest developments in the ever evolving field of infection.

28–29 November 2013 Australasian Tuberculosis Conference 2013

Auckland, New Zealand

This conference follows on from the previous successful event five years ago, with an expanded, multinational and multidisciplinary programme. It is intended to attract health professionals from all disciplines involved with TB throughout New Zealand, Australia and the Western Pacific. The theme of the conference is Tuberculosis - Facing the Challenges.

The goals of the conference are

  • To bring together health professionals involved in TB, to network and share knowledge
  • To disseminate new knowledge and information about all aspects of TB
  • To integrate new knowledge and research concepts into current and future improved practice and research

20–22 February 2014 Antimicrobials 2014

Melbourne, Australia

The programme’s symposia cover many different aspects on antimicrobials and sessions include “Clostridium difficile - Still very Difficult”, “Therapeutic Drug Monitoring - Peaks and Troughs in the Real World”, “Investing in Fungal Futures” , “Bug Time Stories" and "MALDI-TOF Mark 2 - Resistance Detection”. In addition we have two pharmacy workshops on Saturday afternoon titled “TDM in Practice” and "Antimicrobials and Adjunctive Therapies: Controversies and Evidence". Seven proffered papers and two poster sessions are also planned for the meeting.

5–6 March 2014 16th Annual Conference on Superbugs and Superdrugs

London, UK

Key areas to be discussed in this year’s conference are:

• Research and development in neglected diseases
• Horizons for antimicrobial resistance (AMR)
• Controlling the use of new antibiotics
• Public/private partnerships and how you can benefit from it
• The latest treatment for Hepatitis C
• Antibody based strategies
• Nanoparticles approach to treat Gram-Positive and Gram-Negative pathogens
• Regulatory aspects of for new antimicrobials
• Alternative models for tackling antimicrobial resistance

16–21 March 2014 New Antibacterial Discovery & Development

Ventura, CA, USA

This Gordon Research Conference will bring together industry, academic and government leaders involved in the discovery and development of novel antibacterial agents. The discovery of antibiotics and their introduction into clinical practice in the 1940s fundamentally changed the practice of medicine. The increase and spread of antibiotic-resistant bacteria and the reduced investment in this space by the pharmaceutical industry have given rise to the specter of a return to the pre-antibiotic era. Ultimately, it is the goal of the scientific community, and certainly that of the attendees, to forestall that event and to prevent the serious consequences that would come inexorably from it.

20 March 2014 BSAC Spring Meeting 2014

London, UK

The meeting, which regularly attracts over 200 delegates, will be of interest to microbiologists, infectious disease physicians, pharmacists, scientists, infection control specialists, colleagues in industry and professionals allied to the field of infection and antimicrobial chemotherapy.

26–29 March 2014 Annual Scientific Meeting 2014

Adelaide, Australia

The 2014 conference program focuses on providing an innovative and comprehensive review of the latest developments in the rapidly expanding fields of antimicrobial stewardship, infection control, viral hepatitis and Gram negative resistance in addition to other current topics in infectious diseases.

27 July–1 August 2014 International Union of Microbiological Societies Congresses

Montréal, Canada


For the 14th International Congress of Bacteriology and Applied Microbiology, the 14th International Congress of Mycology and the 16th International Congress of Virology, we wish to promote international sharing, cooperation and open discussions on recent advances and perspectives in microbiology research. These congresses bring together the largest, most comprehensive group of microbiology researchers at a single gathering. This world class event draws upon the expertise and experience of organizations and countries from around the globe.

30 August–4 September 2014 Synthetic Biology of Antibiotic Production II

Sant Feliu de Guixols, Spain

This conference will focus on the advancement of synthetic biology, especially its application in the field of antibiotic production in filamentous fungi and actinomycete bacteria, including the implementation and modification of complex biosynthesis pathway modules in existing and new production hosts.

22–24 October 2014 ESCMID Conference on Reviving Old Antibiotics

Vienna, Austria

This conference presents and summarises currently available knowledge regarding optimised clinical use of off-patent antibiotics and will discuss gaps of knowledge and future areas of research as well as adapting breakpoints, enriching treatment guidelines, and implications for regulatory issues. The major expectation for this conference is to drive the optimised usage of old antibiotics, especially indications and dosage regimens, as a key contribution to preserving the efficacy of these essential drugs in an era of escalating multi-drug resistance.

26–28 January 2015 Ist Internacional Caparica Conference in Antibiotic Resistance

Caparica, Portugal

The congress will be focused on the following topics (your comments are welcome):

  • Rise of Antimicrobial Resistance and Epidemiology: Concerns on Pathogen Resistance and Public Health
  • A public health approach to antimicrobial Resistance
  • Genetics of antimicrobial resistance
  • Proteomics of antimicrobial resistance
  • The emergence of antimicrobial resistance in animals
  • Antimicrobial resistance in animal pathogens and its exchange with humans
  • How antimicrobial resistance may be affected by the use of antibiotics in food and agriculture
  • Mechanisms of Antibacterial Resistance
  • Organizing antibiotic surveillance
  • Policies to stimulate drug development and discovery
  • Alternative Strategies to overcome the problem of antimicrobial resistance worldwide
  • Control of resistant infections

26–28 February 2015 Australian Society for Antimicrobials 16th Annual Scientific Meeting “Antimicrobials 2015”

Brisbane, Australia

The programme’s symposia cover many different aspects on antimicrobials and sessions include “Alternative Perspectives on Antimicrobial Use”, “Carbapenemases”, “What to Report and How to Treat”, “Enterococci" and "SMART Platforms”. In addition we have two pharmacy symposia on Saturday afternoon titled “The Bugs and Treatment” and "Antimicrobial Stewardship". Six proffered papers and two poster sessions are also planned for the meeting.

1–4 March 2015 Annual Conference 2015 of the Association for General and Applied Microbiology

Marburg, Germany

The topics for the main symposia will be

  • Microbial Evolution
  • Symbiosis
  • Bacterial Cell Biology
  • CRISPR Systems and Phages
  • Synthetic Microbiology

16–21 March 2015 New Antibacterial Discovery & Development

Ventura, CA, USA

The conference will bring together an international, multi-disciplinary group of researchers from industry, academics, government and foundations and will help lay the groundwork for the next generation of life-saving antibiotics.

18–21 March 2015 2015 ASID Annual Scientific Meeting

Auckland, Australia

The ASID conference is the leading Australasian meeting for adult and paediatric infectious disease and clinical microbiology specialists. The ASM is an ideal opportunity for connecting clinicians, microbiologists and other health professions with a common interest in infectious diseases and provides a friendly forum for the exchange of scientific advances in the prevention, diagnosis and management of clinical infectious diseases.

24–26 March 2015 The 2015 TB Summit

London, UK

This three day international event will explore new research into TB detection, treatments and vaccination as well as new development in controlling and preventing TB Infection.

16–18 April 2015 2015 CACMID-AMMI Canada Annual Conference

Charlottetown, Canada

For more information please refer to the website.

25–28 April 2015 ECCMID 2015

Copenhagen, Denmark

The steady growth in importance of ECCMID has made it our mission to maintain or even increase the excellence of this congress. To achieve this goal the Programme Committee will prepare a series of keynote lectures, symposium, educational workshops and meet-the-expert sessions on parallel tracks, covering the entire field of infectious diseases and clinical microbiology.

2–3 June 2015 Antibiotic Resistance, Uppsala Health Summit 2015

Uppsala, Sweden

Issues to be discussed in workshops and in plenum will cover:

  • measures for rational use of antibiotics for human and veterinarian purposes
  • environmental issues
  • business models for innovation and release of new antibiotics
  • prevention of infections

16–19 June 2015 3rd International Conference on Prevention & Infection Control (ICPIC)

Geneva, Switzerland

Participants from 102 countries attended ICPIC in 2011 and 2013. ICPIC provides a unique forum for the exchange of knowledge and experience in the prevention of healthcare-associated infection and control of antimicrobial resistance around the world. Though advances in infection control and prevention are being made, antimicrobial resistance persists as a global threat confronting all countries alike. The need to share knowledge and experience remains unchanged. ICPIC will be able to provide the necessary platform for such an exchange once again.

16–19 June 2015 3rd International Conference on Prevention & Infection Control (ICPIC)

Geneva, Switzerland

Participants from 102 countries attended ICPIC in 2011 and 2013. ICPIC provides a unique forum for the exchange of knowledge and experience in the prevention of healthcare-associated infection and control of antimicrobial resistance around the world. Though advances in infection control and prevention are being made, antimicrobial resistance persists as a global threat confronting all countries alike. The need to share knowledge and experience remains unchanged. ICPIC will be able to provide the necessary platform for such an exchange once again.

23–24 June 2015 2nd Annual Microbiology & Infectious Diseases Asia Congress 2015


175 delegates from world renowned academic institutions, global pharmaceutical organisations and leading biotechnology companies

50 presentations and case studies focused on the key developments in clinical microbiology, microbial genomics and infectious disease diagnostics

4 interactive streams:

•    Detection Technology & Molecular Diagnostics
•    Clinical Microbiology
•    Microbial Genomics
•    Infectious Diseases

13–16 October 2015 14th International Conference on the Chemistry of Antibiotics and other Bioactive Compounds

Galveston Island, Texas, USA

Conference Topics

Abstract submissions are invited on the conference topics below and should be submitted using the online submission system by the 24 April 2015.

  • Application study of synthetic organic chemistry
  • Pharmaceutical chemistry
  • Microbial chemistry
  • Bioactive natural products
  • Biosynthesis
  • Chemical biology

5–9 September 2016 The World Anti-Microbial Resistance Congress 2016

Washington Court Hotel, Washington, DC

The World AntiMicrobial Resistance Congress USA gathers C-level decision makers from government, funding agencies, pharma, academia, hospitals, labs, and payers to discuss the urgent need for new antibiotics. The Review on Antimicrobial Resistance released their final report this year outlining the rising danger of AMR and the steps that must be taken in order to overcome this danger. This event is about gathering the experts in the industry to determine how best to approach taking these necessary steps.

14–15 November 2016 Superbugs & Superdrugs USA

Iselin, USA

Broadening horizons on the growing global threat of Antimicrobial resistance (AMR) for almost two decades at the sell-out Superbugs & Superdrugs conference in Europe, SMi is thrilled to announce the expansion of its antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA. This year’s show in Iselin, New Jersey, will play host to an audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to discuss the latest clinical advancements and funding opportunities.

6–7 March 2017 The 3rd Biologics & Biosimilars Congress

Berlin, Germany

Attracting industry, regulatory & academic experts working in all areas of protein and antibody research, the 3rd Biologics and Biosimilars Congress 2017 will feature extended panel discussions with senior executives from prominent organisations. Drawing on their experience and insights these leaders will discuss the challenges, opportunities and future direction of a range promising research fields.

23–27 May 2017 The 18th International Symposium on the Biology of Actinomycetes

Jeju, Korea

Bringing together both well-established and promising scientists who are enthusiastic to unfold the treasure hidden in our beloved Actinobacteria, ISBA18 will promote active exchange of ideas and collaborations among researchers of diverse disciplines, academic and cultural backgrounds, from all over the world. The scientific program will accommodate a feast of 13 symposia, 4 workshop sessions, 9 plenary lectures, and a special lecture by 2015 Nobel Laureate Prof. Satoshi Ōmura. Participants will enjoy recent advancements of new knowledges, approaches, techniques, and applications, encompassing nearly all disciplines of modern biology and biotechnology.

11–19 November 2017 International Course on Antibiotics and Resistance (ICARe)

Annecy, France

The goal of ICARe, organized by the Pasteur Institute, is to bring leaders in academics and industry together with early career scientists to provide advanced instruction on antibiotics and resistance. The faculty, composed of 35 internationally recognized scientists and physicians, will be in residence for a minimum of 2 days for informal interactions. Graduates will emerge with a state-of-the-art understanding of existing antibiotics, approaches for mining chemical space for antimicrobial activity, advancing hits to leads, application of nucleic acid-based technologies for antibiotic discovery and resistance detection, and, most importantly, training in thinking innovatively about solutions to the problem.

Back to Top